About | Labcorp Venture Fund

Menu of ~5K clinical laboratory tests with the ability to enable research access to samples
40+ Business Advisory Teams comprised of technical, clinical, and commercial expertise in specific therapeutic areas or technologies to aid in developing new offerings
1,200+ U.S. and international patents and applications
~1,000 boots-on-the-ground diagnostics sales professionals across the U.S.

Work with hospitals and health systems, managed care groups, pharmaceuticals, payers, physicians, employers, patients, CROs, and independent labs
Patient base covering ~50% of the U.S. population with lab orders from 400K+ unique practicing physicians and 3M+ samples collected, processed and reported weekly
Integrated network of primary and specialty labs across the U.S.
In-network service provider for all major health plans and nationally contracted for ~90% of all U.S. lives

Proprietary data sets with 35+ billion core and specialty lab test results
Significant IT connectivity, including 65K+ electronic data interfaces with clients
Data reporting insights, including population health analytics and EHR embedded clinical decision support
Bidirectional interfaces with 700+ EMR, PMS & LIS systems nationwide

Labcorp OnDemand consumer-initiated testing platform with at-home and in-clinic offerings
Mobile and web-enabled tools allowing consumers to make appointments, access test results, and pay bills
Integration of Ovia’s digital health platform focusing on family and women’s health, offering clinical programs, predictive intervention and personalized care pathways
2,000+ patient service centers, 6,000+ in-office phlebotomists, ~400 Labcorp at Walgreens locations, and numerous at home solutions

Clinical trial activity in ~100 countries with 4.5M+ trial supply kits shipped annually
Patient intelligence portal for voice of customer insights and direct-to-patient surveys regarding clinical research opportunities and trial design preferences
Decentralized clinical trial solutions to reduce patient and investigator burden, enable new sites, and improve enrollment
Technology innovations spanning non-clinical and cell and gene therapy development services

About Us